Thursday May 15, 2014
South Burlington resident Joseph Brayden, Ph.D., a University of Vermont professor of pharmacology, has been named a 2014 Distinguished Investigator by the Cardiovascular Research Institute of Vermont (CVRI-VT) at the University of Vermont College of Medicine and Fletcher Allen Health Care. The CVRI-VT, a collaborative of cardiovascular researchers from a wide range of departments and disciplines across the university medical center, selected six members for this inaugural award.Founded in 2002 by the late Burton Sobel, M.D., former chair of medicine at UVM/Fletcher Allen, the CVRI-VT has been led by David Schneider, M.D., professor of medicine and director of cardiovascular services, since August 2013.
Brayden and the other 2014 Distinguished Investigators were recognized at a special celebration event held April 17, 2014 at the Fleming Museum at UVM.
“These six researchers represent a breadth and depth of expertise and experience that would be hard to match at any institution in the country,” says Schneider. “It is an honor to work with such an outstanding collaborative of physicians and scientists as we highlight excellence in cardiovascular research and foster development of the next generation of distinguished investigators.”
Among the CVRI’s goals are improving communication across disciplines, departments and colleges, and encouraging interdepartmental collaborations at UVM and Fletcher Allen. The Institute also aims to increase cardiovascular funding support and advance and highlight cardiovascular research excellence at national and international levels. The newly-invigorated Institute’s planned initiatives include monthly research forums featuring cardiovascular experts, beginning in fall 2014.